Niche clinical SnapIoT offers a DIY self-service mClinical platform that enables rapid, code-free design and deployment of digital clinical trials, presenting a compelling option for sponsors seeking faster trial setup and reduced vendor dependence.

End-to-end integration The platform supports end-to-end trial workflows with modules for eQualification, eConsent, EDC, and ePRO/COA, plus a wide library of connectors to EDCs, EMR/EHRs, wearables and electronic signatures, opening upsell opportunities across data capture, regulatory compliance, and analytics ecosystems.

Device native snapClinical runs in native device code across iOS and Android, enabling full device capabilities for patient engagement, which can be leveraged to differentiate from web-based competitors and justify premium, device-centric deployments.

Strategic partnerships Existing integrations with ActiGraph and other third-party providers suggest a pathway to expand collaborations with digital health sensors, labs, beacons, and CLIA facilities to broaden data streams and trial complexity.

Growth potential With a lean team and revenue in the low to mid single-digit millions, SnapIoT is positioned to target mid-market sponsors and niche CROs seeking agile, cost-efficient mClinical solutions, offering upsell from DIY licenses to turnkey deployments.